2024-01-012024-12-312024-12-31false14562942GENO GROUP LIMITED2025-08-0162012falseiso4217:GBPxbrli:pure145629422023-12-31145629422024-12-31145629422024-01-012024-12-31145629422022-12-29145629422023-12-31145629422022-12-302023-12-3114562942bus:SmallEntities2024-01-012024-12-3114562942bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3114562942bus:FullAccounts2024-01-012024-12-3114562942bus:PrivateLimitedCompanyLtd2024-01-012024-12-3114562942core:WithinOneYear2024-12-3114562942core:AfterOneYear2024-12-3114562942core:WithinOneYear2023-12-3114562942core:AfterOneYear2023-12-3114562942core:ShareCapital2024-12-3114562942core:SharePremium2024-12-3114562942core:RevaluationReserve2024-12-3114562942core:OtherReservesSubtotal2024-12-3114562942core:RetainedEarningsAccumulatedLosses2024-12-3114562942core:ShareCapital2023-12-3114562942core:SharePremium2023-12-3114562942core:RevaluationReserve2023-12-3114562942core:OtherReservesSubtotal2023-12-3114562942core:RetainedEarningsAccumulatedLosses2023-12-3114562942core:LandBuildings2024-12-3114562942core:PlantMachinery2024-12-3114562942core:Vehicles2024-12-3114562942core:FurnitureFittings2024-12-3114562942core:OfficeEquipment2024-12-3114562942core:NetGoodwill2024-12-3114562942core:IntangibleAssetsOtherThanGoodwill2024-12-3114562942core:ListedExchangeTraded2024-12-3114562942core:UnlistedNon-exchangeTraded2024-12-3114562942core:LandBuildings2023-12-3114562942core:PlantMachinery2023-12-3114562942core:Vehicles2023-12-3114562942core:FurnitureFittings2023-12-3114562942core:OfficeEquipment2023-12-3114562942core:NetGoodwill2023-12-3114562942core:IntangibleAssetsOtherThanGoodwill2023-12-3114562942core:ListedExchangeTraded2023-12-3114562942core:UnlistedNon-exchangeTraded2023-12-3114562942core:LandBuildings2024-01-012024-12-3114562942core:PlantMachinery2024-01-012024-12-3114562942core:Vehicles2024-01-012024-12-3114562942core:FurnitureFittings2024-01-012024-12-3114562942core:OfficeEquipment2024-01-012024-12-3114562942core:NetGoodwill2024-01-012024-12-3114562942core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3114562942core:ListedExchangeTraded2024-01-012024-12-3114562942core:UnlistedNon-exchangeTraded2024-01-012024-12-3114562942core:MoreThanFiveYears2024-01-012024-12-3114562942core:Non-currentFinancialInstruments2024-12-3114562942core:Non-currentFinancialInstruments2023-12-3114562942dpl:CostSales2024-01-012024-12-3114562942dpl:DistributionCosts2024-01-012024-12-3114562942core:LandBuildings2024-01-012024-12-3114562942core:PlantMachinery2024-01-012024-12-3114562942core:Vehicles2024-01-012024-12-3114562942core:FurnitureFittings2024-01-012024-12-3114562942core:OfficeEquipment2024-01-012024-12-3114562942dpl:AdministrativeExpenses2024-01-012024-12-3114562942core:NetGoodwill2024-01-012024-12-3114562942core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3114562942dpl:GroupUndertakings2024-01-012024-12-3114562942dpl:ParticipatingInterests2024-01-012024-12-3114562942dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3114562942core:ListedExchangeTraded2024-01-012024-12-3114562942dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3114562942core:UnlistedNon-exchangeTraded2024-01-012024-12-3114562942dpl:CostSales2022-12-302023-12-3114562942dpl:DistributionCosts2022-12-302023-12-3114562942core:LandBuildings2022-12-302023-12-3114562942core:PlantMachinery2022-12-302023-12-3114562942core:Vehicles2022-12-302023-12-3114562942core:FurnitureFittings2022-12-302023-12-3114562942core:OfficeEquipment2022-12-302023-12-3114562942dpl:AdministrativeExpenses2022-12-302023-12-3114562942core:NetGoodwill2022-12-302023-12-3114562942core:IntangibleAssetsOtherThanGoodwill2022-12-302023-12-3114562942dpl:GroupUndertakings2022-12-302023-12-3114562942dpl:ParticipatingInterests2022-12-302023-12-3114562942dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-302023-12-3114562942core:ListedExchangeTraded2022-12-302023-12-3114562942dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-302023-12-3114562942core:UnlistedNon-exchangeTraded2022-12-302023-12-3114562942core:NetGoodwill2024-12-3114562942core:IntangibleAssetsOtherThanGoodwill2024-12-3114562942core:LandBuildings2024-12-3114562942core:PlantMachinery2024-12-3114562942core:Vehicles2024-12-3114562942core:FurnitureFittings2024-12-3114562942core:OfficeEquipment2024-12-3114562942core:AfterOneYear2024-12-3114562942core:WithinOneYear2024-12-3114562942core:ListedExchangeTraded2024-12-3114562942core:UnlistedNon-exchangeTraded2024-12-3114562942core:ShareCapital2024-12-3114562942core:SharePremium2024-12-3114562942core:RevaluationReserve2024-12-3114562942core:OtherReservesSubtotal2024-12-3114562942core:RetainedEarningsAccumulatedLosses2024-12-3114562942core:NetGoodwill2023-12-3114562942core:IntangibleAssetsOtherThanGoodwill2023-12-3114562942core:LandBuildings2023-12-3114562942core:PlantMachinery2023-12-3114562942core:Vehicles2023-12-3114562942core:FurnitureFittings2023-12-3114562942core:OfficeEquipment2023-12-3114562942core:AfterOneYear2023-12-3114562942core:WithinOneYear2023-12-3114562942core:ListedExchangeTraded2023-12-3114562942core:UnlistedNon-exchangeTraded2023-12-3114562942core:ShareCapital2023-12-3114562942core:SharePremium2023-12-3114562942core:RevaluationReserve2023-12-3114562942core:OtherReservesSubtotal2023-12-3114562942core:RetainedEarningsAccumulatedLosses2023-12-3114562942core:NetGoodwill2022-12-2914562942core:IntangibleAssetsOtherThanGoodwill2022-12-2914562942core:LandBuildings2022-12-2914562942core:PlantMachinery2022-12-2914562942core:Vehicles2022-12-2914562942core:FurnitureFittings2022-12-2914562942core:OfficeEquipment2022-12-2914562942core:AfterOneYear2022-12-2914562942core:WithinOneYear2022-12-2914562942core:ListedExchangeTraded2022-12-2914562942core:UnlistedNon-exchangeTraded2022-12-2914562942core:ShareCapital2022-12-2914562942core:SharePremium2022-12-2914562942core:RevaluationReserve2022-12-2914562942core:OtherReservesSubtotal2022-12-2914562942core:RetainedEarningsAccumulatedLosses2022-12-2914562942core:AfterOneYear2024-01-012024-12-3114562942core:WithinOneYear2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3114562942core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3114562942core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3114562942core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3114562942core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3114562942core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3114562942core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3114562942core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3114562942core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3114562942core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3114562942core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3114562942core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3114562942bus:Director12024-01-012024-12-3114562942bus:Director22024-01-012024-12-31

GENO GROUP LIMITED

Registered Number
14562942
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

GENO GROUP LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

GUI, Shengyue
ZHANG, Yi Ian

Company Secretary

EIK BUSINESS LIMITED

Registered Address

35 Pond Street
London
NW3 2PN

Registered Number

14562942 (England and Wales)
GENO GROUP LIMITED
Statement of Financial Position
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets32,896,025-
Tangible assets4553-
Investments518-
2,896,596-
Current assets
Debtors6,72,351,873423,977
Cash at bank and on hand1,222,6062,228,420
3,574,4792,652,397
Creditors amounts falling due within one year8(2,409,516)(1,200)
Net current assets (liabilities)1,164,9632,651,197
Total assets less current liabilities4,061,5592,651,197
Creditors amounts falling due after one year9-(370,309)
Net assets4,061,5592,280,888
Capital and reserves
Called up share capital4,403,8604,232,966
Share premium1,390,155-
Profit and loss account(1,732,456)(1,952,078)
Shareholders' funds4,061,5592,280,888
The financial statements were approved and authorised for issue by the Board of Directors on 1 August 2025, and are signed on its behalf by:
GUI, Shengyue
Director
ZHANG, Yi Ian
Director

Registered Company No. 14562942
GENO GROUP LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A, as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Borrowing costs
Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale. Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
Finance costs
Finance costs charged to the profit or loss include interest expense calculated using the effective interest method from FRS 102:11, finance charges on finance leases, and exchange differences on foreign currency borrowings where these are treated as an adjustment to interest costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Tangible fixed assets and depreciation
Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount. Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year22
3.Intangible assets

Other

Total

££
Cost or valuation
Additions2,896,0252,896,025
At 31 December 242,896,0252,896,025
Net book value
At 31 December 242,896,0252,896,025
At 31 December 23--
4.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions922922
At 31 December 24922922
Depreciation and impairment
Charge for year369369
At 31 December 24369369
Net book value
At 31 December 24553553
At 31 December 23--
5.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
Additions1818
At 31 December 241818
Net book value
At 31 December 241818
At 31 December 23--

Notes

1Investments in group undertakings and participating interests
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables35,776-
Other debtors246,56816,977
Total282,34416,977
7.Debtors: amounts due after one year

2024

2023

££
Amounts owed by group undertakings 2,069,529407,000
Total2,069,529407,000
8.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables1,000,637-
Amounts owed to related parties833,028-
Accrued liabilities and deferred income575,8511,200
Total2,409,5161,200
9.Creditors: amounts due after one year

2024

2023

££
Amounts owed to related parties-370,309
Total-370,309